Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Akeso, Inc. ( (HK:9926) ) has provided an update.
Akeso, Inc. has successfully completed the placing of new and existing shares, raising approximately HK$3,493.01 million in net proceeds. The funds will primarily be used for global and China R&D of its innovative pipeline, including clinical trials for cancer treatments and the development of next-generation therapeutic technology platforms.
The most recent analyst rating on (HK:9926) stock is a Buy with a HK$177.00 price target. To see the full list of analyst forecasts on Akeso, Inc. stock, see the HK:9926 Stock Forecast page.
More about Akeso, Inc.
Akeso, Inc. is a company incorporated in the Cayman Islands, operating in the biotechnology industry. It focuses on research and development of innovative therapeutic products, particularly in the field of oncology, with a market focus on both global and China regions.
Average Trading Volume: 12,851,517
Technical Sentiment Signal: Buy
Current Market Cap: HK$139.8B
Find detailed analytics on 9926 stock on TipRanks’ Stock Analysis page.